Inactivated Polio And Rabies Vaccines Market To Witness 5.5% CAGR Growth Through 2030: Key Industry Drivers
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Inactivated Polio And Rabies Vaccines Market Size And Revenue Outlook Through 2030
The inactivated polio and rabies vaccines market has seen significant growth in recent years. It is projected to expand from $2.27 billion in 2025 to $2.4 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.5%. This historical expansion can be attributed to global polio eradication initiatives, a rise in rabies incidence due to animal bites, the expansion of national immunization programs, increased public sector vaccine procurement, and WHO and UNICEF vaccination mandates.
The inactivated polio and rabies vaccines market is poised for significant expansion in the upcoming years. It is forecast to achieve a valuation of $2.97 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.5%. This projected growth is driven by an intensified focus on eliminating rabies deaths, increasing pediatric immunization rates in emerging economies, better access to healthcare in rural regions, a rise in demand for adult post-exposure prophylaxis, and stronger infrastructure for pandemic preparedness. Throughout the forecast period, notable trends include the broadening of combination inactivated polio vaccine (IPV) and rabies immunization programs, a shift towards intradermal rabies vaccination for improved dose efficiency, stronger cold chain and vaccine logistics, more government-led mass immunization efforts, and greater adoption of WHO-prequalified inactivated vaccines.
Get A Free Sample Report With In-Depth Market Insights:
Inactivated Polio And Rabies Vaccines Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing need for effective vaccination initiatives is projected to drive the expansion of the inactivated polio and rabies vaccines market. These programs, which are organized efforts by entities or governments to provide vaccines for disease protection, are on the rise due to stronger governmental pushes to curb outbreaks, reduce healthcare expenditures, and improve public health. Vaccination campaigns bolster the demand for inactivated polio and rabies vaccines by increasing awareness, securing funding, and expanding coverage in vulnerable regions. Sustained vaccine uptake is achieved through large-scale campaigns and regular immunizations spearheaded by governments and health organizations. For example, in April 2024, the Pan American Health Organization (PAHO), a US-based specialized agency, initiated the 22nd Vaccination Week in the Americas (VWA) under the theme Engage now to protect your future GetVax. This event aimed to raise vaccination coverage, particularly in underserved regions, by delivering over 65 million doses, while also countering misinformation and improving vaccine access via community engagement and customized campaigns. Consequently, the escalating demand for robust vaccination programs is fueling the growth of the inactivated polio and rabies vaccines market.
Inactivated Polio And Rabies Vaccines Market Segment Landscape And Growth Outlook
The inactivated polio and rabies vaccines market covered in this report is segmented –
1) By Product Type: Inactivated Polio Vaccine, Inactivated Rabies Vaccine
2) By Method Of Inactivation: Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, Other Method Of Inactivations
3) By Distribution Channel: Government, Private
4) By Application: Pediatrics, Adults
Subsegments:
1) By Inactivated Polio Vaccine: Injectable Inactivated Polio Vaccine, Oral Inactivated Polio Vaccine
2) By Inactivated Rabies Vaccine: Injectable Inactivated Rabies Vaccine, Intradermal Inactivated Rabies Vaccine
#Inactivated Polio And Rabies Vaccines Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the inactivated polio and rabies vaccines market are concentrating on developing advanced products, such as killed virus rabies vaccines, to enhance immunogenicity and address the growing global demand for effective disease prevention. These killed virus rabies vaccines are formulated using the rabies virus that has been rendered non-infectious through chemical or physical processes. Such vaccines stimulate the immune system to produce protective antibodies without causing the disease, thus ensuring both safety and effectiveness in pre- and post-exposure prophylaxis. For example, in April 2024, Sanofi, a UK-based pharmaceutical company, introduced Verorab, an inactivated rabies vaccine, in the UK for the pre-exposure and post-exposure prophylaxis of rabies across all age groups. This vaccine, licensed in the UK based on extensive clinical data from over 13,000 individuals, has been broadly utilized in more than 80 countries. Verorab presents an effective immunization choice for travelers heading to high-risk nations and for treatment following rabies exposure, with clinical trials indicating strong immune responses and prolonged protection.
Inactivated Polio And Rabies Vaccines Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the inactivated polio and rabies vaccines market are Merck & Co Inc., Sanofi S.A., LG Chem Ltd., Boehringer Ingelheim International GmbH, Sinovac Biotech, Zoetis Inc., Cadila Pharmaceuticals, Zydus Lifesciences Limited, Biological E. Limited, Serum Institute of India (SII), Indian Immunologicals Limited (IIL), Instituto Butantan, Valneva SE, Bio Farma, Bharat Biotech, Bilthoven Biologicals, Panacea Biotec, Batavia Biosciences, Hilleman Laboratories, China National Pharmaceutical Group Co Ltd.
View The Full Inactivated Polio And Rabies Vaccines Market Report:
Inactivated Polio And Rabies Vaccines Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the inactivated polio and rabies vaccines market in 2025. The regions covered in the inactivated polio and rabies vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
